跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANDESARTAN HCT SANDOZ TABLET 16mg/12.5mg - HSA Drug Approval Details
Approvals
/
HSA
/
CANDESARTAN HCT SANDOZ TABLET 16mg/12.5mg
Approved
THERAPEUTIC
CANDESARTAN HCT SANDOZ TABLET 16mg/12.5mg
Lek Pharmaceuticals d.d. (Ljubljana)Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary Packager)
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 2018
Approval ID
0f30803aa391b312
Company
Lek Pharmaceuticals d.d. (Ljubljana)Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary Packager)
Type
Therapeutic
Approval Details
Approval Id
0f30803aa391b312
Drug Name
CANDESARTAN HCT SANDOZ TABLET 16mg/12.5mg
Product Name
CANDESARTAN HCT SANDOZ TABLET 16mg/12.5mg
Approval Number
SIN15503P
Approval Date
2018-06-07
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09DA06
Atc Item Name
candesartan and diuretics
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Hydrochlorothiazide
12.5mg
Candesartan cilexetil
16mg
CANDESARTAN CILEXETIL
16 MG
HYDROCHLOROTHIAZIDE
12.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 2018
Approval ID
0f30803aa391b312
Type
Therapeutic
Back to HSA Approvals